Found 10 results
Author Title [ Type(Desc)] Year
Filters: Author is Young, Lowell S  [Clear All Filters]
Journal Article
L. E. Bermudez, Motamedi, N., Chee, C., Baimukanova, G., Kolonoski, P., Inderlied, C., Aralar, P., Wang, G., Phan, L. Tam, and Young, L. S., “EDP-420, a bicyclolide (bridged bicyclic macrolide), is active against Mycobacterium avium.”, Antimicrobial agents and chemotherapy, vol. 51, no. 5, pp. 1666-70, 2007.
L. Danelishvili, Wu, M., Young, L. S., and Bermudez, L. E., “Genomic approach to identifying the putative target of and mechanisms of resistance to mefloquine in mycobacteria.”, Antimicrobial agents and chemotherapy, vol. 49, no. 9, pp. 3707-14, 2005.
L. Danelishvili, Wu, M., Young, L. S., and Bermudez, L. E., “Genomic approach to identifying the putative target of and mechanisms of resistance to mefloquine in mycobacteria.”, Antimicrob Agents Chemother, vol. 49, no. 9, pp. 3707-14, 2005.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Chee, C. B., Aralar, P., Petrofsky, M., Parman, T., Green, C. E., Lewin, A. H., Ellis, W. Y., and Young, L. S., “Identification of (+)-Erythro-Mefloquine as an Active Enantiomer with Greater Efficacy than Mefloquine against Mycobacterium avium Infection in Mice.”, Antimicrobial agents and chemotherapy, vol. 56, no. 8, pp. 4202-6, 2012.
L. Danelishvili, Young, L. S., and Bermudez, L. E., “In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium.”, Microbial drug resistance (Larchmont, N.Y.), vol. 12, no. 1, pp. 1-6, 2006.
L. Danelishvili, Young, L. S., and Bermudez, L. E., “In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium.”, Microb Drug Resist, vol. 12, no. 1, pp. 1-6, 2006.
L. E. Bermudez, Kolonoski, P., Petrofsky, M., Wu, M., Inderlied, C. B., and Young, L. S., “Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.”, The Journal of infectious diseases, vol. 187, no. 12, pp. 1977-80, 2003.
L. E. Bermudez, Kolonoski, P., Seitz, L. E., Petrofsky, M., Reynolds, R., Wu, M., and Young, L. S., “SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.”, Antimicrobial agents and chemotherapy, vol. 48, no. 9, pp. 3556-8, 2004.
G. Carter, Young, L. S., and Bermudez, L. E., “A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation.”, Antimicrobial agents and chemotherapy, vol. 48, no. 12, pp. 4907-10, 2004.
L. E. Bermudez, Reynolds, R., Kolonoski, P., Aralar, P., Inderlied, C. B., and Young, L. S., “Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice.”, Antimicrobial agents and chemotherapy, vol. 47, no. 8, pp. 2685-7, 2003.